Clinical Trial Update: Utility of CYP2D6 Genotyping to Improve the Efficacy and Safety of Tramadol [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether CYP2D6 genotyping improves the efficacy and safety of tramadol for post-surgical pain, with unclear status at this time.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Post-surgical Pain
• Postoperative Pain

Drugs mentioned

• Tramadol (tramadol)

Snippet

Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Conditions: Post-surgical Pain, Pain, Acute | Phase 4 | Status: UNKNOWN